Transcription co-factor EYA2 and transcription factor PAX6 are highly conserved proteins, which are regulated by each other. Previous studies show that EYA2 and PAX6 mediate invasion and metastasis of breast cancer via TGF-β-Smad induced epithelial-mesenchymal transition and are associated with poor prognosis, respectively. Our preliminary data reveal that EYA2 interacts with PAX6, co-expression of EYA2 and PAX6 correlates with decreased expression of key factors in TGF-β-Smad signaling pathway and shortened survival, suggesting that the interaction of EYA2 and PAX6 promotes invasion and metastasis of breast cancer. However, it remains unknown how invasion and metastasis are regulated by the interaction between EYA2 and PAX6, and the underlying mechanisms. Based on these findings, we aims to employ Co-IP, CRISPR/Cas9 induced gene knockout, tumor invasion and migration assays, and in vivo metastasis assay to define the domain that regulates the interaction between EYA2 and PAX6, and investigate the molecular mechanisms of PAX6-induced breast cancer invasion and metastasis regulated by EYA2 via TGF-β-Smad induced epithelial-mesenchymal transition. Our research will lay the foundation for developing novel anti-cancer agents targeting EYA2-PAX6 complex to improve the treatment of breast cancer.
EYA2和PAX6是具有相互调节关系的两个保守蛋白,对EYA2或PAX6研究发现,两者均可通过TGF-β-Smad信号通路调节的上皮-间质转化参与乳腺癌侵袭和转移,且与患者不良预后有关。本项目组前期研究发现,EYA2能与PAX6结合,共同高表达可使TGF-β-Smad信号通路中关键因子表达升高、患者生存率显著降低,提示EYA2通过与PAX6相互作用促进乳腺癌侵袭和转移。但是,两者如何共同调控以及调控机制尚未明确。在此基础上,本项目拟利用Co-IP、CRISPR/Cas9介导的基因敲除技术,通过细胞侵袭和迁移实验和构建移植瘤模式动物等,探索EYA2-PAX6相互作用的结构基础;研究EYA2与PAX6相互作用对TGF-β-Smad信号通路调节的上皮-间质转化等影响并阐述其调控乳腺癌侵袭和转移的分子机制,为开发抑制EYA2-PAX6结合的抗癌药物提供研究基础,为有效地防治乳腺癌提供新思路。
EYA2和PAX6是具有相互调节关系的两个保守蛋白,对EYA2或PAX6研究发现,两者均可通过TGF-β-Smad信号通路调节的上皮-间质转化参与乳腺癌侵袭和转移,且与患者不良预后有关。本项目组前期研究发现,EYA2能与PAX6结合,共同高表达可使TGF-β-Smad信号通路中关键因子表达升高、患者生存率显著降低,提示EYA2通过与PAX6相互作用促进乳腺癌侵袭和转移。但是,两者如何共同调控以及调控机制尚未明确。在此基础上,本项目拟利用Co-IP、CRISPR/Cas9介导的基因敲除技术,通过细胞侵袭和迁移实验和构建移植瘤模式动物等,探索EYA2-PAX6相互作用的结构基础;研究EYA2与PAX6相互作用对TGF-β-Smad信号通路调节的上皮-间质转化等影响并阐述其调控乳腺癌侵袭和转移的分子机制,为开发抑制EYA2-PAX6结合的抗癌药物提供研究基础,为有效地防治乳腺癌提供新思路。
{{i.achievement_title}}
数据更新时间:2023-05-31
外泌体在胃癌转移中作用机制的研究进展
结直肠癌免疫治疗的多模态影像及分子影像评估
肺部肿瘤手术患者中肺功能正常吸烟者和慢阻肺患者的小气道上皮间质转化
宫颈癌发生与ApoE、CLU和RelB表达调控 的关系及意义
油源断裂输导和遮挡配置油气成藏有利部位预测方法及其应用
miR-30a和miR-338通过EYA2调控乳腺癌生长和转移的机制研究
lncRNA ERBC通过结合FUBP1和KHSRP调控乳腺癌侵袭转移的分子机制研究
Rho通过调控MYH9介导乳腺癌侵袭转移的机制研究
PLUNC与Vitronectin相互作用通过整合素相关信号调控鼻咽癌侵袭转移的分子机制